Have Complications Related to Balloon Pulmonary Angioplasty Changed Since its Inception?

Balloon pulmonary angioplasty: Evolution over time and its complications


Balloon pulmonary angioplasty (BPA) has grown from its beginnings as an indication for patients with chronic thromboembolic pulmonary hypertension (CTEPH) to being currently a class 1 indication for inoperable patients and/or residual CTEPH. Current evidence on this topic is underpowered, as most reports are based on a small number of patients.

¿Han cambiado las complicaciones relacionadas a la angioplastia pulmonar con balón desde sus inicios? 

Researchers conducted a systematic review on papers reporting on BPA and its results. In addition, the rate of complications related to BPA was analyzed for two time periods, 2013-2017 and 2018-2022. 

The primary endpoint (PEP) was the incidence of BPA-related complications, defined as vessel injury or hemoptysis, use of mechanical ventilation, or procedure-related death.

The analysis included a total of 1714 CTEPH patients, who accounted for a total of 7561 BPA sessions. The mean follow-up was 7.3 months after the procedure. Results showed that the incidence of hemoptysis or vessel injury was 11.1%, the rate of reperfusion edema was 6%, the rate of mechanical ventilation was 0.4%, and the mortality rate was 1.3%.

Read also: AQCA Study: Pre-PCI Virtual QFR for Planning PCI vs. Conventional Angiography.

When complications were analyzed over the two time periods, the cumulative incidence of hemoptysis and vessel injury decreased from 14.1% to 7.7% (p < 0.01), reperfusion edema decreased from 11.3% to 1.4% (p < 0.01), mechanical ventilation decreased from 0.7% to 0.1% (p < 0.01), and even mortality decreased from 2% to 0.8% (p < 0.01).

Conclusion

BPA is running its natural course, becoming a safe procedure as time goes by. Further research is needed to improve procedural technique, patient selection, and treated lesion characteristics.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Periprocedural Complications With Balloon Pulmonary Angioplasty Analysis of Global Studies 

Reference: Nishant Jain, MD et al J Am Coll Cardiol Intv 2023.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....